TY - JOUR
KW - Comorbidity
KW - Humans
KW - Opiate Overdose/prevention & control
KW - Opiate Substitution Treatment
KW - Opioid-Related Disorders/diagnosis/prevention & control
KW - Primary Health Care
KW - Risk Factors
KW - United States
AU - J. L. Taylor
AU - J. H. Samet
A1 - 
AB - Opioid use disorder (OUD) is a treatable chronic disorder with episodes of remission and recurrence characterized by loss of control of opioid use, compulsive use, and continued use despite harms. If untreated, OUD is associated with significant morbidity and mortality. Buprenorphine and methadone reduce fatal and nonfatal opioid overdose and infectious complications of OUD and are the first-line treatment options. Physicians have an important role to play in diagnosing OUD and its comorbidities, offering evidence-based treatment, and delivering overdose prevention and other harm reduction services to people who continue to use opioids. Interdisciplinary office-based addiction treatment programs support high-quality OUD care.
AD - Section of General Internal Medicine, Boston University School of Medicine and Boston Medical Center, and Grayken Center for Addiction, Boston Medical Center, Boston, Massachusetts.; Section of General Internal Medicine, Boston University School of Medicine and Boston Medical Center, and Grayken Center for Addiction, Boston Medical Center, Boston, Massachusetts.
BT - Annals of Internal Medicine
C5 - Education & Workforce; Opioids & Substance Use
CP - 1
CY - United States
DO - 10.7326/AITC202201180
IS - 1
JF - Annals of Internal Medicine
LA - eng
M1 - Journal Article
N2 - Opioid use disorder (OUD) is a treatable chronic disorder with episodes of remission and recurrence characterized by loss of control of opioid use, compulsive use, and continued use despite harms. If untreated, OUD is associated with significant morbidity and mortality. Buprenorphine and methadone reduce fatal and nonfatal opioid overdose and infectious complications of OUD and are the first-line treatment options. Physicians have an important role to play in diagnosing OUD and its comorbidities, offering evidence-based treatment, and delivering overdose prevention and other harm reduction services to people who continue to use opioids. Interdisciplinary office-based addiction treatment programs support high-quality OUD care.
PP - United States
PY - 2022
SN - 1539-3704; 0003-4819
SP - ITC1
EP - ITC16
EP - 
T1 - Opioid Use Disorder
T2 - Annals of Internal Medicine
TI - Opioid Use Disorder
U1 - Education & Workforce; Opioids & Substance Use
U2 - 35007147
U3 - 10.7326/AITC202201180
VL - 175
VO - 1539-3704; 0003-4819
Y1 - 2022
Y2 - Jan
ER -